Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels

American Journal of Cardiology

Volumn 86, Issue 2, 2000, Pages 221-223

  Kastelein, John J P ^a   Isaacsohn, Jonathan L ^b   Ose, Leiv ^c   Hunninghake, Donald B ^d   Frohlich, Jiri ^e   Davidson, Michael H ^f   Habib, Rafik ^g   Dujovne, Carlos A ^f   Crouse III, John R ^h   Liu, Minzhi ⁱ   Melino, Michael R ⁱ   O'Grady, Laura ⁱ   Mercuri, Michele ⁱ   Mitchel, Yale B ⁱ  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Metabolic and Atherosclerosis Research Center   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Heart Disease Prevention Clinic   (United States)

^e ST PAUL S HOSPITAL   (Canada)

^f RADIANT RESEARCH   (United States)

^g Centre Cardio Vasculaire de Laval   (Canada)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034126502     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00942-5     Document Type: Article

References (7)

1. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA. 269:1993;3015-3023.
2. Rubins H.B., Robins S.J., Collins D., Fye C.L., Anderson J.W., Elam M.B., Faas F.H., Linares E., Schaefer E.J., Schectman G., Wilt T.J., Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 341:1999;410-418.
3. Crouse J.R. III, Frohlich J., Ose L., Mercuri M., Tobert J.A. Effects of high doses of simvastatin and atovastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiol. 83:1999;1476-1477.
4. Jones P., Kafonek S., Laurora I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The CURVES study). Am J Cardiol. 81:1998;582-587.
5. Dart A., Jerums G., Nicholson G., d'Emden M., Hamilton-Craig I., Tallis G., Best J., West M., Sullivan D., Bracs P., Black D. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol. 80:1997;39-44.
6. Naoumova R.P., Dunn S., Rallidis L., Abu-Muhana O., Neuwirth C., Rendell N.B., Taylor G.W., Thompson G.R. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin. J Lipid Res. 38:1997;1496.
7. Hoogerbrugge N., Jansen H. Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia. Atherosclerosis. 146:1999;167-174.